Novo Nordisk to invest $158 million in insulin plant in Brazil
SAO PAULO (Reuters) – Danish drugmaker Novo Nordisk will invest 864 million reais ($158.2 million) to revamp a plant in Brazil responsible for pumping out a quarter of its insulin production globally, the firm said on Friday. The funds will overhaul the Montes Claros factory, in the southeastern state of Minas Gerais, and implement sustainable…